The largest community of pharma leaders

Ethris Announces Expansion of Leadership Team

MUNICH–(BUSINESS WIRE)–Ethris GmbH, a leader in mRNA-based therapeutics with specific expertise in pulmonary disease, announced today the expansion of the company’s leadership team by the addition of Thomas Langenickel, M.D. in the role of Chief Medical Officer. Dr. Langenickel joins Ethris from Novartis AG, where he was Executive Director and Head of Respiratory Profiling within the Translational Medicine Group. “Thomas has a wealth of experience in guiding novel programs from discovery …


Recent Articles